Sanofi is now accepting submissions for the 2022 Sanofi Golden Ticket Competition!
Sanofi is a global sponsor of BioLabs, a premier shared laboratory space for life science and biotech startups to test new ideas and innovate. Sanofi is sponsoring an inaugural global Golden Ticket Competition that will award three promising start-up companies a one-year pre-paid residence at one of the respective sponsored BioLabs sites:
The two key focus areas for 2022 addressing therapeutic challenges in oncology, immuno-inflammation, neuroscience, rare diseases & vaccine are:
- Targeted or controlled delivery and conditional activation of biologics or genomic medicines to increase tissue specific exposure
- New and next generation genome editing technologies with breakthrough potential for in vivo therapeutics
All companies, based in Europe and United States, and engaged in these fields are encouraged to apply.
Deadline to apply for the Sanofi Golden Ticket is February 11, 2022.
How to apply
A sub-set of applicants will be selected as finalists, and will be invited to present at the virtual Sanofi Golden Ticket Pitch Showcase on March 31, 2022.
By submitting an application, applicants represent and warrant that they have read, understand and agree to the Official Rules.
To apply, read the Official Rules, and download and complete the application form.